← SynDRA
TEDIZOLID
SynDRA canonical compound SYN0024739 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Mechanism of action | bacterial 50S ribosomal subunit inhibitor |
| Indication | skin infections |
| Disease area | infectious disease |
Mechanisms of action (all sources)
- bacterial 50S ribosomal subunit inhibitor
Cross-references
Synonyms
- TR-700
- Sivextro
- Torezolid
- TR 700
- DA-7157
- UNII-97HLQ82NGL
- 97HLQ82NGL
- CHEBI:82717
- (5R)-3-[3-fluoro-4-[6-(2-methyltetrazol-5-yl)-3-pyridyl]phenyl]-5-(hydroxymethyl)oxazolidin-2-one
- Tedizolid [USAN:INN]
- Tedizolid (USAN/INN)
- SCHEMBL440398
- CHEMBL1257051
- DTXSID10234975
- XFALPSLJIHVRKE-GFCCVEGCSA-N
- MolPort-042-624-220
- AI025
- BCP02830
- ZINC43100956
- AKOS025401974
- CS-0687
- NCGC00379072-02
- AN-27109
- AK322133
- AC-27738
- BC600578
- HY-14855
- Tedizolid phosphate
- Torezolid phosphate
- Tedizolid (phosphate)
- UNII-O7DRJ6R4DW
- CHEBI:83326
- O7DRJ6R4DW
- TR-701
- TR-701-FA
- (R)-(3-(3-fluoro-4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)-2-oxooxazolidin-5-yl)methyl dihydrogen phosphate
- NE63553
- [(5R)-3-{3-fluoro-4-[6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl]phenyl}-2-oxo-1,3-oxazolidin-5-yl]methyl dihydrogen phosphate
- (R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one dihydrogenphos
Reported adverse events
- Headache
- Myelosuppression
- Nausea
- Dizziness
- Vomiting
- Infusion
Look up TEDIZOLID in the interactive SynDRA portal →